Biblio print

Tree Display

AceDB Schema

XML Display


Author Report for: Markesbery WR

No contact information in database for Markesbery WR

    Title: Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB
    Nelson PT, Kryscio RJ, Abner EL, Schmitt FA, Jicha GA, Mendiondo MS, Cooper G, Smith CB, Markesbery WR
    Ref: J Alzheimers Dis, 16:29, 2009 : PubMed


    Title: Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease
    Pettigrew LC, Bieber F, Lettieri J, Wermeling DP, Schmitt FA, Tikhtman AJ, Ashford JW, Smith CD, Wekstein DR and Gulanski B <4 more author(s)>
    Ref: Journal of Clinical Pharmacology, 38:236, 1998 : PubMed


    Title: Santavuori disease: diagnosis by leukocyte ultrastructure
    Baumann RJ, Markesbery WR
    Ref: Neurology, 32:1277, 1982 : PubMed


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page

Acknowledgements and disclaimer